Stockscreener 앱 받기
3.915
0.25%
0.015
전일 마감가:
$3.90
열려 있는:
$3.89
하루 거래량:
165.17K
Relative Volume:
0.12
시가총액:
$391.42M
수익:
$58.36M
순이익/손실:
$-25.72M
주가수익비율:
-10.75
EPS:
-0.3641
순현금흐름:
$-24.91M
1주 성능:
+0.77%
1개월 성능:
-5.79%
6개월 성능:
+43.75%
1년 성능:
-15.55%
1일 변동 폭
$3.86
$3.925
1주일 범위
$3.82
$4.0892
52주 변동 폭
$2.12
$5.80
Aquestive Therapeutics Inc Stock (AQST) Company Profile
명칭
Aquestive Therapeutics Inc
전화
908-941-1900
주소
30 TECHNOLOGY DRIVE, WARREN, NJ
AQST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AQST
Aquestive Therapeutics Inc
|
3.925 | 466.96M | 58.36M | -25.72M | -24.91M | -0.3641 |
|
ZTS
Zoetis Inc
|
155.25 | 68.78B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.79 | 47.59B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.6992 | 43.40B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.01 | 20.79B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
306.07 | 13.81B | 2.99B | 1.21B | 1.13B | 25.06 |
Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2024-12-17 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-05-10 | 개시 | Leerink Partners | Outperform |
| 2024-04-11 | 개시 | Piper Sandler | Overweight |
| 2024-03-28 | 개시 | Raymond James | Outperform |
| 2021-04-07 | 재개 | RBC Capital Mkts | Outperform |
| 2019-04-22 | 개시 | H.C. Wainwright | Buy |
| 2019-01-03 | 개시 | Lake Street | Buy |
| 2018-08-20 | 개시 | JMP Securities | Mkt Outperform |
| 2018-08-20 | 개시 | RBC Capital Mkts | Outperform |
모두보기
Aquestive Therapeutics Inc 주식(AQST)의 최신 뉴스
Aquestive Therapeutics Inc. recovery potential after sell offPortfolio Risk Report & Fast Exit Strategy with Risk Control - Newser
Will Aquestive Therapeutics Inc. outperform the marketWeekly Stock Recap & Daily Oversold Bounce Ideas - Newser
Why Aquestive Therapeutics Inc. is moving todayJuly 2025 Sector Moves & Breakout Confirmation Trade Signals - Newser
Analyzing recovery setups for Aquestive Therapeutics Inc. investorsWeekly Trade Report & AI Enhanced Market Trend Forecasts - Newser
Aquestive Therapeutics Inc. stock daily chart insightsJuly 2025 Price Swings & Short-Term Swing Trade Alerts - Newser
Should you wait for a breakout in Aquestive Therapeutics Inc.July 2025 Sector Moves & Risk Managed Trade Strategies - Newser
Aquestive Therapeutics shares rise 2.56% after-hours after announcing participation in three investor conferences in September. - AInvest
Institutional scanner results for Aquestive Therapeutics Inc.July 2025 WrapUp & Precise Entry and Exit Recommendations - Newser
Comparing Aquestive Therapeutics Inc. in custom built stock radarsJuly 2025 Final Week & Low Drawdown Trading Strategies - Newser
Aquestive Therapeutics shares fall 1% after-hours as management participates in upcoming investor conferences. - AInvest
Using portfolio simulators with Aquestive Therapeutics Inc. includedTrade Volume Report & Long-Term Safe Investment Ideas - Newser
What’s next for Aquestive Therapeutics Inc. stock priceEarnings Overview Summary & AI Driven Stock Movement Reports - Newser
Technical analysis overview for Aquestive Therapeutics Inc. stock2025 Historical Comparison & AI Powered Buy and Sell Recommendations - Newser
Analyzing net buyer seller activity in Aquestive Therapeutics Inc.Market Trend Report & High Return Trade Guides - Newser
Can Aquestive Therapeutics Inc. Bounce Back From Weekly Low2025 AllTime Highs & AI Driven Stock Price Forecasts - beatles.ru
Analyzing drawdowns of Aquestive Therapeutics Inc. with statistical toolsLong Setup & Weekly Top Performers Watchlists - Newser
Aquestive Therapeutics to Participate in Upcoming September Investor Conferences - GlobeNewswire
Pharma Innovation Leader Aquestive Therapeutics Announces Triple Conference Presence in September 2025 - Stock Titan
Order flow analysis tools used on Aquestive Therapeutics Inc.Trade Risk Report & Risk Adjusted Buy and Sell Alerts - Newser
Is this a good reentry point in Aquestive Therapeutics Inc.Quarterly Trade Review & Capital Efficient Trading Techniques - Newser
Earnings visualization tools for Aquestive Therapeutics Inc.Profit Target & AI Forecasted Stock Moves - Newser
Is Aquestive Therapeutics Inc. stock entering bullish territoryBull Run & Daily Stock Momentum Reports - Newser
How to track smart money flows in Aquestive Therapeutics Inc.Layoff News & Verified Momentum Stock Alerts - Newser
Machine Learning Models Forecast Aquestive Therapeutics Inc. UptickEarnings Growth Summary & Long-Term Investment Growth Plans - 더경남뉴스
Applying Elliott Wave Theory to Aquestive Therapeutics Inc.Weekly Investment Summary & Risk Adjusted Buy/Sell Alerts - Newser
Aquestive Therapeutics Announces $85M Stock Offering - MSN
Price action breakdown for Aquestive Therapeutics Inc.July 2025 Summary & High Yield Equity Trading Tips - Newser
Aquestive Therapeutics Inc. stock retracement – recovery analysisPortfolio Update Summary & Free Fast Gain Swing Trade Alerts - Newser
Evaluating Aquestive Therapeutics Inc. with trendline analysisWeekly Stock Summary & Daily Technical Stock Forecast Reports - Newser
Chart based exit strategy for Aquestive Therapeutics Inc.Product Launch & High Win Rate Trade Alerts - Newser
What are Aquestive Therapeutics Inc.’s recent SEC filings showingRate Cut & Risk Managed Investment Entry Signals - theviewers.co.kr
Will Aquestive Therapeutics Inc. price bounce be sustainableRisk Management & High Conviction Trade Alerts - Newser
Pattern recognition hints at Aquestive Therapeutics Inc. upsideAnalyst Downgrade & Real-Time Buy Signal Alerts - Newser
Aquestive's Anaphylm to be reviewed by Health Canada - MSN
Unlocking Growth in Specialty Pharma: RTW Biotech's Strategic $75M Investment in Aquestive's Anaphylm - AInvest
Aquestive outlines patient-first Anaphylm launch strategy and maintains 2025 revenue guidance amid FDA review progress - MSN
$160m War Chest Readied For Aquestive’s Oral Epinephrine Film Launch - insights.citeline.com
Aquestive signs $75m agreement for launch of Anaphylm - Yahoo Finance
Can Aquestive Therapeutics Inc. ride the EV waveQuarterly Performance Summary & Long-Term Safe Investment Ideas - thegnnews.com
Real time breakdown of Aquestive Therapeutics Inc. stock performanceQuarterly Investment Review & Free Expert Approved Momentum Trade Ideas - Newser
Understanding Aquestive Therapeutics Inc.’s price movementMarket Sentiment Report & Short-Term High Return Strategies - Newser
AQST FY2025 EPS Forecast Raised by Cantor Fitzgerald - Defense World
Aquestive Therapeutics Inc (AQST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.48%
0.18%
자본화:
|
볼륨(24시간):